ADIPOQ and metabolic syndrome: Researchers had an early focus on “metabolic syndrome” (#2), “coronary revascularization” (#3), “psychological” (#7), and “health insurance” (#8), followed by “psoriatic arthritis” (#0), “autoimmune disease” (#6), “arthritis” (#9), and “adiponectin” (#10).